Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06120465 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

YOGA-CF (Yoga Outcomes Get Assessed in Cystic Fibrosis)

Study acronym: YOGA-CF
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 29, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary and study completion dates: Oct 30, 2025 to Jan 31, 2026
    • Site details revised
    • Eligibility criteria expanded, about 4 words
    v3
  2. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Start date changed from estimate of Dec 1, 2023 to Apr 22, 2024
    • Primary endpoint revised
    • Primary and study completion dates: Jul 10, 2025 to Oct 30, 2025
    • Secondary endpoints expanded, about 32 words
    • Site details revised
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to investigate the effects of yoga participation for adults with cystic fibrosis. The main question it aims to answer is: does participation in yoga affect health-related quality of life for adults with cystic fibrosis? Researchers will compare a group completing a 12-week yoga programme alongside usual cystic fibrosis care, to a group completing usual care alone to see if the addition of yoga effects health-related quality of life.
Trial Details
NCT Number NCT06120465
Lead Sponsor Royal Brompton & Harefield NHS Foundation Trust
Conditions
(from sponsor)
Cystic Fibrosis
Related terms Cystic Fibrosis
Enrollment 314 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov